FDA reduces monitoring time for Amgen’s Imdelltra infusions

Imdelltra is a targeted immunotherapy designed to bind to DLL3 proteins, activating the immune system to target SCLC cells. Credit: MY STOCKERS/Shutterstock.com.



  • FDA Amgen Imdelltra